Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 6Melanoma 3Neoplasm Metastasis 2Adenocarcinoma of Lung 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Ovarian Neoplasms 1Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder) 1Neuroendocrine Tumors 1Myeloproliferative Disorders 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1HIV Infections 1Fallopian Tube Neoplasms 1Congenital Abnormalities 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Neuroendocrine 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 5tislelizumab 2spartalizumab 2Trastuzumab 2Psychiatric Rehabilitation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-12 Subunit p35 2Erlotinib Hydrochloride 2Biopsy 2trastuzumab deruxtecan 1tipifarnib 1regorafenib 1prexasertib 1niraparib 1fludarabine 1enzalutamide 1entinostat 1abiraterone 1Vorinostat 1Thalidomide 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Ritonavir 1Radiotherapy 1Radionuclide Imaging 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × CTLA-4 Antigen × Thoracic × Clear all
NCT02408861 2026-01-21

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
79 enrolled 24 charts
GastrointestinalSarcomaThoracic

Anus Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡